EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
63 hedge funds and large institutions have $215M invested in Eiger BioPharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
Holders
63
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$2.62M | |
| 2 | +$975K | |
| 3 | +$890K | |
| 4 |
BC
Broadfin Capital
New York
|
+$699K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$695K |
Top Sellers
| 1 | -$6.62M | |
| 2 | -$1.27M | |
| 3 | -$566K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$514K |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$497K |